Warren, R B, Blauvelt, A, Poulin, Y, Beeck, S, Kelly, M, Wu, T, Geng, Z & Paul, C 2020, ' Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge) : Results from a phase 3, randomised, open-label, efficacy assessor-blinded clinical trial ', The British journal of dermatology . https://doi.org/10.1111/bjd.19341
Leonardi, C, Papp, K, Strober, B, Thaçi, D, Warren, R B, Tyring, S, Arikan, D, Karunaratne, M & Valdecantos, W C 2019, ' Comprehensive Long-Term Safety of Adalimumab from Eighteen Clinical Trials in Adult Patients With Moderate to Severe Plaque Psoriasis ', The British journal of dermatology, vol. 180, no. 1, pp. 76-85 . https://doi.org/10.1111/bjd.17084